The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease

Research output: Contribution to journalArticlepeer-review

95 Scopus citations

Abstract

Despite the widely held belief that there are no effective medical therapies for peripheral arterial disease (PAD), current data suggest that medical therapies can effectively modify the natural history of atherosclerotic lower extremity arterial occlusive disease. The ideal medical therapy would improve claudication, forestall the onset of limb-threatening events, decrease rates of invasive interventional therapies and improve long- term patient survival. These ideal outcomes might be achieved through the use of smoking cessation interventions, including behavioral and pharmacological therapy, and the administration of antiplatelet and lipid-lowering medications in patients with PAD.

Original languageEnglish (US)
Pages (from-to)243-251
Number of pages9
JournalVascular Medicine
Volume2
Issue number3
DOIs
StatePublished - 1997

Keywords

  • Aspirin
  • Cholesterol
  • Claudication
  • Nicotine
  • Peripheral arterial disease
  • Tobacco

Fingerprint Dive into the research topics of 'The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease'. Together they form a unique fingerprint.

Cite this